Cargando…
Direct-acting antiviral retreatment patterns for hepatitis C
BACKGROUND: Despite the strong efficacy of direct-acting antivirals (DAAs) against the hepatitis C virus, many patients require a second regimen of DAA treatment. However, limited research exists to characterize rates of retreatment across different DAA agents or potential factors that may increase...
Autores principales: | Hasan, Shaquib Al, Dauner, Daniel G, Rajpurohit, Abhijeet, Farley, Joel F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372973/ https://www.ncbi.nlm.nih.gov/pubmed/36125057 http://dx.doi.org/10.18553/jmcp.2022.28.10.1100 |
Ejemplares similares
-
Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
por: Kanda, Tatsuo, et al.
Publicado: (2017) -
Retreatment for hepatitis C virus direct‐acting antiviral therapy virological failure in primary and tertiary settings: The REACH‐C cohort
por: Carson, Joanne M., et al.
Publicado: (2022) -
National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents
por: Ferraz, Maria Lúcia Gomes, et al.
Publicado: (2022) -
Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C
por: Abdulla, Maheeba, et al.
Publicado: (2022) -
Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals
por: Ahmed, Asma, et al.
Publicado: (2015)